Efficiency of local cytokine therapy used in the combination treatment of female patients with chronic cystitis
26–36 million cases of urinary tract infections are registered annually in Russia. An exacerbation of cystitis within 6 months after the start of the primary episode occurs in about one-third of patients and it turns into a chronic relapsing form in 10%. It is the recurring nature of chronic cystitis, which substantially worsens quality of life in female patients and increases the number of cases of temporary disability, determining the socioeconomic significance of this disease. Objective: To evaluate the efficiency of combination treatment in patients with chronic recurrent cystitis using local cytokine therapy (Superlymph) in combination with antibacterial therapy. Subjects and methods. The prospective randomized study enrolled 60 women whose mean age was 34.7±15.7 years. After the screening period, the patients were randomized into two groups in a 1:1 ratio: 1) 30 women who received combination therapy (antibacterial therapy + Superlymph) and 2) 30 women who used monotherapy (antibacterial therapy). A control group consisted of 10 healthy women (mean age 29.8±9.3 years). A control group consisted of 10 healthy women (mean age 29.8±9.3 years). Group 1 patients used one rectal 25-U Superlymph suppository once daily for 10 days at Visit 1 and Visit 3. The total duration of therapy was 20 days. As an antibacterial drug, fosfomycin trometamol was used at a single 3-g dose overnight in both groups. The investigation involved 4 planned visits and the following steps: screening, therapy, and follow-up. Bladder diaries and an acute cystitis symptom scale (ACSS) were used to evaluate the severity of the disease. Results. Dysuric disorders (painful, frequent urination, burning, etc.) were noted in all the patients included in the study. Analyzing the bladder diaries revealed that the average number of times to urinate per day was 12.8±5.3; daytime and nighttime urinations were 9.6±4.5 and 3.5±0.9, respectively. At the same time, the urge to micturate was recorded in 57 (95.0%) patients and urge urinary incontinence was noted in 3 (5.0%). Mild, moderate, and severe symptoms were diagnosed in 7 (11.7%), 48 (80.0%), and (8.3%) patients, respectively. Group 1 patients receiving combination treatment (antibacterial therapy + Superlymph) showed a significant reduction in clinical symptoms (by 24.6±3.7 ACSS scores) and also a decrease in leukocyturia, as evidenced by the general urinalysis, and normalization of the urinary flora compared with the monotherapy group (Group 2) (by 13.1±4.9 scores) (p <0.001). The investigation conducted after treatment demonstrated that in Group 1, the proportion of pathogenic and opportunistic microflora significantly decreased compared to the baseline data. Conclusion. The findings show that the incorporation of Superlymph into combination treatment for chronic recurrent cystitis may enhance therapeutic efficiency by 2.6 times, prolongs remission between exacerbations by an average of 30.3±5.9 days, and improves quality of life in patients.Apolikhina I.A., Saidova A.S., Teterina T.A.
Keywords
chronic recurrent cystitis
dysuric disorders
local cytokine therapy
quality of life
References
- Борисов В.В. Диагностика и терапия инфекций мочевыводящих путей. О чем следует помнить всегда (клиническая лекция). Часть 1. Урологические ведомости. 2017; 7(3): 52–9. [Borisov VV. Diagnosis and theraphy of urinary infections. What should always remember (clinical lecture). Part 1. Urologicheskie vedomosti. 2017; 7(3): 52–9. (in Russian)]. doi: 10.17816/uroved7352-59
- Курилович Н.В. Рациональная фармакотерапия хронического бактериального цистита в стадии обострения у женщин. Вестник Тамбовского университета. Серия Естественные и технические науки. 2017; 22(6): 1676–1679. [Kurilovich N.V. rational pharmacotherapy of the chronic bacterial cystitis in the stage of women exacerbation. Vestnik Tambovskogo universiteta. Seriya Estestvennye i tekhnicheskie nauki — Tambov University Reports. Series: Natural and Technical Sciences. 2017; 22(6): 1676–1679. (in Russian)]. doi: 10.20310/1810-0198-2017-22-6-1676-1679
- Шолан Р.Ф., Гараев Г.Ш., Насруллаева Г.М. Интерстициальный цистит: синдром болезненного мочевого пузыря. Казанский медицинский журнал. 2018; 99(1): 84–91. [Sholan R.F., Garaev G.S., Nasrullaeva G.M. Interstitial cystitis: painful bladder syndrome. Kazan medical journal. 2018; 99(1): 84–91. (in Russian)]. doi: 10.17816/KMJ2018-084
- Birder L.A., Hanna-Mitchell А.Т., Mayer E., Buffington Ch. A. Cystitis, Comorbid Disorders and Associated Epithelial Dysfunction. Neurourol Urodyn. 2011; 30(5): 668–72. doi: 10.1002/nau.21109
- Захарова И.Н., Османов И.М., Касьянова А.Н., Мумладзе Э.Б., Мачнева Е.Б., Лупан И.Н. Протективные факторы слизистой оболочки мочевого пузыря – ключ к новым подходам к терапии инфекции мочевых путей. Рос вестн перинатол и педиатр. 2018; 63(2): 16–21. [Zakharova I.N., Osmanov I.M., Kasyanova A.N., Mumladze E.B., Machneva E.B., Lupan I.N. Protective factors of the urinary bladder mucous membrane - the key to new approaches of urinary tract infection therapy. Ros Vestn Perinatol i Pediatr. 2018; 63(2): 16–21. (in Russian)]. doi: 10.21508/1027-4065-2018-63-2-16-21
- Grover S., Srivastava A., Lee R., et al. Role of inflammation in bladder function and interstitial cystitis. Ther. Adv. Urol. 2011; 3(1): 19–33. doi: 10.1177/1756287211398255
- Minardi D., d’Anzeo G., Cantoro D., et al. Urinary tract infections in women: etiology and treatment options. Intern. J. General Med. 2011; 4: 333–4. doi: 10.2147/IJGM.S11767
- Persu C., Cauni V., Gutue S., et al. From interstitial cystitis to chronic pelvic pain. J. Med. and Life. 2010; 3(2): 167–74. PMCID: PMC3019050
- Lamale L.M., Lutgendorf S.K., Zimmerman M.B., Kreder K.J. Interleukin-6, histamine and methylhistamine as diagnostic markers for interstitial cystitis. Urology. 2006; 68: 702–6. doi: 10.1016/j.urology.2006.04.033
- Gonzalez E.J., Arms L., Vizzard M.A. The Role(s) of Cytokines/Chemokines in Urinary Bladder Inflammation and Dysfunction. BioMed Research International. 2014; 2014: Article ID 120525. https://doi.org/10.1155/2014/120525.
- Локшин К.Л. Как терапия урологических заболеваний влияет на микробиом: стандартные подходы в сравнении с альтернативными (реферат статьи). Consilium Medicum. 2018; 20 (7): 69–72. doi: 10.26442/2075-1753_2018.7.69–72. [Lokshin K.L. How the microbiome is influenced by the therapy of urological diseases: standard versus alternative approaches (article summary). Consilium Medicum. 2018; 20(7): 69–72. (in Russian)]. doi: 10.26442/2075-1753_2018.7.69-72
- Доброхотова Ю.Э., Мандрыкина Ж.А., Нариманова М.Р. Несостоявшийся выкидыш. Причины и возможности реабилитации. Российский вестник акушера-гинеколога. 2016; 16(4): 85–90. [Dobrokhotova Yu.E., Mandrykina Zh.A., Narimanova M.R. Missed abortion: Reasons and possibilities for rehabilitation. Rossiyskiy vestnik akushera-ginekologa/Russian Bulletin of Obstetrician-Gynecologist. 2016; 16(4): 85–90. (in Russian)]. doi:10.17116/rosakush201616485-90.
Received 01.11.2019
Accepted 29.11.2019
About the Authors
Inna A. Apolikhina, MD, PhD, Professor, Head of Department of Aesthetic Gynecology and Rehabilitation, V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4, Akademika Oparina st., Moscow, 117997, Russian Federation; I.M.Sechenov First Moscow State Medical University, Federation. 8, 2, Trubetskaia st., Moscow, 119991, Russian Federation, Tel.: +74957351055///. E-mail: apolikhina@inbox.ru.Aina S. Saidova, PhD, obstetrician-gynecologist of the Department of Aesthetic Gynecology and Rehabilitation, V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4, Akademika Oparina st., Moscow, 117997, Russian Federation, Tel.: +79262066051. E-mail: asekova14@yandex.ru.
Tatyana A. Teterina, PhD, obstetrician-gynecologist of the Department of Aesthetic Gynecology and Rehabilitation, V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, 4, Akademika Oparina st., Moscow, 117997, Russian Federation, Tel.: +7(963)961-67-44. E-mail: palpebra@inbox.ru.
For citation: Apolikhina I.A., Saidova A.S., Teterina T.A. Efficiency of local cytokine therapy used in the combination treatment of female patients with chronic cystitis.
Akusherstvo i Ginekologiya / Obstetrics and gynecology. 2019; 12: 167-72.(In Russian).
https://dx.doi.org/10.18565/aig.2019.12.167-172
Similar Articles
